'First-in-human' drug for malignant glioma available in experimental trial
Wednesday, February 15, 2012 - 12:02
in Health & Medicine
The UC Cancer Institute is one of three centers internationally approved to test an experimental drug's safety and pharmacokinetics and also assess the clinical benefit against recurrent malignant glioma, an aggressive form of brain cancer.